Bone marrow examination is widely used in the staging and management of solid cancers. In lung cancer, previous studies have suggested that bone marrow examination is useful in staging small cell anaplastic carcinoma but rarely reveals unsuspected metastases in other forms of primary lung tumour (Hansen, 1983) . Recent experience in breast cancer has shown that occult metastases to lymph nodes and bone marrow can be detected more easily by the use of monoclonal antibodies than by conventional microscopical examination (Redding et al., 1983; Wells et al., 1984; Ghosh et al., 1985) . This finding has raised the possibility that similar occult metastases may be present in patients with lung cancer and might explain the early development of bony deposits in patients with histologically uninvolved marrow aspirates at presentation. The present study was undertaken to determine whether immunocytochemical examination with anti-epithelial monoclonal antibodies known to react reliably with all types of lung cancer (Gatter et al., 1985) would have any advantages over conventional morphology in recognizing metastatic deposits in the bone marrow of patients presenting with lung cancer.
Bone marrow was aspirated from the iliac crest of 38 patients at, or soon after, a diagnosis of primary lung cancer. The tumour types were: small cell (11 cases), squamous cell (15 cases), large cell anaplastic (8 cases) and adenocarcinoma (3 cases). Air-dried smears were prepared in the routine way and one or two stained by the May GrunewaldGiemsa technique. The remainder were fixed in acetone:methanol (1:1) and immunostained by the alkaline phosphatase: anti-alkaline phosphatase (APAAP) method as described previously (Cordell Morphological studies have demonstrated marrow infiltration in 12-45% of patients presenting with small cell anaplastic carcinoma although the figure is much lower in other forms of lung cancer (<4%) (Hansen, 1983 (Gatter et al., 1985) , no cases of occult micrometastases were detected. Indeed the 3 anticytokeratins were selected for this study by virtue of their largely homogeneous staining of lung tumours. This is different to the reported incident of occult micrometastases in the bone marrow in patients presenting with breast cancer. In these patients immunocytochemical staining has been shown to identify micrometastases in 24% of marrows which were otherwise reported as uninvolved by tumour (Redding et al., 1983) . We ourselves have made similar findings in 10 cases of carcinoma from several different primary sites (Ghosh et al., 1985) .
In conclusion, this study suggests that at present immunocytochemistry has little to offer over conventional morphological examination in the staging of patients presenting with carcinoma of the lung. However, we are continuing to examine marrows in patients with lung cancer in order to confirm these results on a larger series.
